Cargando…

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients

The costly and burdensome nature of the current follow-up methods in non-muscle-invasive bladder cancer (NMIBC) drives the development of new methods that may alternate with regular cystoscopy and urine cytology. The Uromonitor-V2(®) is a new urine-based assay in the detection of hotspot mutations i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sieverink, Caroline A., Batista, Rui P. M., Prazeres, Hugo J. M., Vinagre, João, Sampaio, Cristina, Leão, Ricardo R., Máximo, Valdemar, Witjes, J. Alfred, Soares, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599569/ https://www.ncbi.nlm.nih.gov/pubmed/32987933 http://dx.doi.org/10.3390/diagnostics10100745

Ejemplares similares

Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
por: Batista, Rui, et al.
Publicado: (2020)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
por: Batista, Rui, et al.
Publicado: (2020)

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
por: Batista, Rui, et al.
Publicado: (2019)

Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
por: Soares, Paula, et al.
Publicado: (2011)

TERTmonitor—qPCR Detection of TERTp Mutations in Glioma
por: Brás, João Paulo, et al.
Publicado: (2023)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer
por: Prazeres, Hugo, et al.
Publicado: (2011)

Corrigendum to “How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer”
por: Prazeres, Hugo, et al.
Publicado: (2016)

Bladder cancer recurrence surveillance by urine metabolomics analysis
por: Loras, A., et al.
Publicado: (2018)

Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer
por: Lamarca, Angela, et al.
Publicado: (2012)

Follow-up in non-muscle invasive bladder cancer: facts and future
por: Witjes, J. Alfred
Publicado: (2020)

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
por: Melo, Miguel, et al.
Publicado: (2014)

Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert(®) Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer
por: Cowan, Barrett, et al.
Publicado: (2021)

Urine cell-based DNA methylation classifier for monitoring bladder cancer
por: van der Heijden, Antoine G., et al.
Publicado: (2018)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow‐up of non‐muscle‐invasive bladder cancer: a blinded prospective multicentric study
por: Gontero, Paulo, et al.
Publicado: (2020)

Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
por: Witjes, J Alfred, et al.
Publicado: (2021)

Experimental rat bladder urothelial cell carcinoma models
por: Arentsen, Harm C., et al.
Publicado: (2009)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application
por: Canberk, Sule, et al.
Publicado: (2021)

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
por: Reinert, Thomas
Publicado: (2012)

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Topic issue on new treatments in bladder cancer
por: Witjes, J. A.
Publicado: (2009)

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
por: van der Heijden, Antoine G., et al.
Publicado: (2007)

Catarrh of the Bladder; Albumen in the Urine
por: Thompson, Henry
Publicado: (1880)

New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine
por: Monreal-Trigo, Javier, et al.
Publicado: (2022)

The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype
por: Amorim, João P., et al.
Publicado: (2016)

Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors
por: Pereira, Luísa, et al.
Publicado: (2012)

Intravesical hyperthermia and mitomycin-C for carcinoma in situ of the urinary bladder: experience of the European Synergo(®) working party
por: Alfred Witjes, J., et al.
Publicado: (2009)

Long-Term Experience with Radiofrequency-Induced Hyperthermia Combined with Intravesical Chemotherapy for Non-Muscle Invasive Bladder Cancer
por: Brummelhuis, Iris S. G., et al.
Publicado: (2021)

The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
por: Kamat, Ashish M., et al.
Publicado: (2016)

Epigenetic Markers for Bladder Cancer in Urine
por: Kim, Wun-Jae, et al.
Publicado: (2007)

Translation and validation of two disease-specific patient-reported outcome measures (Bladder Cancer Index and FACT-Bl-Cys) in Dutch bladder cancer patients
por: Michels, Charlotte T. J., et al.
Publicado: (2019)

The prognostic value of family history among patients with urinary bladder cancer
por: Egbers, Lieke, et al.
Publicado: (2015)

Pathway-guided monitoring of the disease course in bladder cancer with longitudinal urine proteomics
por: Carvalho, Luís Botelho, et al.
Publicado: (2023)

Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
por: Lammers, Rianne J. M., et al.
Publicado: (2015)

Oropouche virus detection in saliva and urine
por: do Nascimento, Valdinete Alves, et al.
Publicado: (2020)

Inherited Thyroid Tumors With Oncocytic Change
por: Correia, Marcelo, et al.
Publicado: (2021)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4f12uj37ialuahe8lejutaekn7